Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vandenberghe

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Haematologica|June 8, 2006
Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13)Hilde Janssen, Iwona Wlodarska, Cristina Mecucci, et al.
British Journal of Haematology|May 2, 2023
Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusionQuentin Van Thillo, Barbara Dewaele, Jolien De Bie, et al.
British Journal of Haematology|March 12, 2014
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1Carla Al Assaf, Els Lierman, Timothy Devos, et al.
Haematologica|August 1, 2009
The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradationFederica Toffalini, Anders Kallin, Peter Vandenberghe, et al.
Acta Clinica Belgica|October 17, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals LeuvenJan Brijs, Jonas Van Ham, Benedicte Dubois, et al.
Acta Clinica Belgica|September 18, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals LeuvenJan Brijs, Jonas Van Ham, Benedicte Dubois, et al.
Genes, Chromosomes & Cancer|July 28, 2010
Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasiaNatalie Put, Heidi Lemmens, Iwona Wlodarska, et al.
European Journal of Immunology|February 6, 2002
Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed micePeter W Hellings, Peter Vandenberghe, Ahmad Kasran, et al.
Oncotargets and Therapy|March 21, 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma PatientsMichel Delforge, Jolien Raddoux, Corine Antonis, et al.
Genes, Chromosomes & Cancer|March 31, 2007
Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndromeHelena Agerstam, Henrik Lilljebjörn, Carin Lassen, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Haematologica|June 8, 2006
Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13)Hilde Janssen, Iwona Wlodarska, Cristina Mecucci, et al.
British Journal of Haematology|May 2, 2023
Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusionQuentin Van Thillo, Barbara Dewaele, Jolien De Bie, et al.
British Journal of Haematology|March 12, 2014
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1Carla Al Assaf, Els Lierman, Timothy Devos, et al.
Haematologica|August 1, 2009
The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradationFederica Toffalini, Anders Kallin, Peter Vandenberghe, et al.
Acta Clinica Belgica|October 17, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals LeuvenJan Brijs, Jonas Van Ham, Benedicte Dubois, et al.
Acta Clinica Belgica|September 18, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals LeuvenJan Brijs, Jonas Van Ham, Benedicte Dubois, et al.
Genes, Chromosomes & Cancer|July 28, 2010
Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasiaNatalie Put, Heidi Lemmens, Iwona Wlodarska, et al.
European Journal of Immunology|February 6, 2002
Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed micePeter W Hellings, Peter Vandenberghe, Ahmad Kasran, et al.
Oncotargets and Therapy|March 21, 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma PatientsMichel Delforge, Jolien Raddoux, Corine Antonis, et al.
Genes, Chromosomes & Cancer|March 31, 2007
Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndromeHelena Agerstam, Henrik Lilljebjörn, Carin Lassen, et al.
Pageof 19